SignatureFD
TXG icon

SignatureFD’s 10x Genomics TXG Stock Holding History

SignatureFD’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$248K Buy
2,740
+43
+2% +$2.52K ﹤0.01% 1035
2026
Q2 		$103K Sell
2,697
-84
-3% -$2.2K ﹤0.01% 1424
2026
Q1 		$59K Buy
2,781
+148
+6% +$2.96K ﹤0.01% 1636
2025
Q4 		$42.9K Buy
2,633
+33
+1% +$499 ﹤0.01% 1741
2025
Q3 		$30.4K Hold
2,600
– – ﹤0.01% 1903
2025
Q2 		$30.1K Sell
2,600
-1,603
-38% -$14.6K ﹤0.01% 1871
2025
Q1 		$36.7K Buy
4,203
+2,409
+134% +$30.4K ﹤0.01% 1744
2024
Q4 		$25.8K Buy
1,794
+1,452
+425% +$22.9K ﹤0.01% 1934
2024
Q3 		$7.72K Buy
342
+215
+169% +$4.44K ﹤0.01% 2439
2024
Q2 		$2.47K Sell
127
-62
-33% -$1.62K ﹤0.01% 2707
2024
Q1 		$7.09K Sell
189
-38
-17% -$1.67K ﹤0.01% 2432
2023
Q4 		$12.7K Sell
227
-104
-31% -$4.52K ﹤0.01% 2149
2023
Q3 		$13.7K Sell
331
-6
-2% -$312 ﹤0.01% 2042
2023
Q2 		$18.8K Buy
337
+40
+13% +$2.16K ﹤0.01% 1924
2023
Q1 		$16.6K Buy
297
+102
+52% +$4.76K ﹤0.01% 1969
2022
Q4 		$7.11K Buy
195
+110
+129% +$3.6K ﹤0.01% 2291
2022
Q3 		$2K Sell
85
-187
-69% -$7.12K ﹤0.01% 2853
2022
Q2 		$12K Buy
272
+165
+154% +$8.56K ﹤0.01% 2048
2022
Q1 		$8K Buy
107
+25
+30% +$2.19K ﹤0.01% 2292
2021
Q4 		$12K Buy
82
+72
+720% +$11K ﹤0.01% 2048
2021
Q3 		$1K Buy
10
+4
+67% +$687 ﹤0.01% 2936
2021
Q2 		$1K Buy
6
+1
+20% +$181 ﹤0.01% 2843
2021
Q1 		$1K Buy
+5
New +$863 ﹤0.01% 2689
2020
Q4 		– Sell
-12
Closed -$1K – 2706
2020
Q3 		$1K Sell
12
-2
-14% -$210 ﹤0.01% 2510
2020
Q2 		$1K Buy
+14
New +$1.09K ﹤0.01% 2398

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return

SignatureFD's TXG Position: Q3 2026 in Review

SignatureFD increased its 10x Genomics (TXG) stake by 1.6% in Q3 2026, buying an estimated $2.52K and bringing the position to 2,740 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

SignatureFD first reported a position in TXG in Q2 2020 and has held it in 25 quarters since. 257 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • SignatureFD held 2,740 shares of 10x Genomics worth $248K as of Q3 2026.
  • SignatureFD bought 43 10x Genomics shares in Q3 2026, an estimated $2.52K.
  • 10x Genomics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1035 holding.
  • SignatureFD first reported a position in 10x Genomics in Q2 2020 and has held it in 25 quarters since.
  • 257 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.